March 10, 2025 · Form 4 insider transaction
Dickinson Andrew D bought 11,090 shares of Gilead Sciences, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.; The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.